The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics' oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness.
from CNN.com - RSS Channel - World https://ift.tt/3wey1RX
via
IFTTT
No comments:
Post a Comment